Potential use of biomarkers for analyzing interpopulation and cross-cultural variability in reproductive aging

Menopause

Volumn 14, Issue 4, 2007, Pages 668-679

  Bentley, Gillian R ^a   Muttukrishna, Shanthi ^b  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anti mullerian hormone; Biomarkers; Follicles; Inhibin B; Ovarian reserve; Ovarian volume; Reproductive aging; Variability

Indexed keywords

BIOLOGICAL MARKER; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

AGING; ATRESIA; BLOOD ANALYSIS; COMPARATIVE STUDY; CONFERENCE PAPER; CULTURAL ANTHROPOLOGY; DOCUMENTATION; ECHOGRAPHY; FECES ANALYSIS; FEMALE GENITAL SYSTEM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MEASUREMENT; MEDICAL DOCUMENTATION; MENSTRUAL CYCLE; ORGAN SIZE; OVARY; OVARY DEVELOPMENT; OVARY FOLLICLE; OVARY FUNCTION; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; SALIVA ANALYSIS; URINALYSIS;

BIOLOGICAL MARKERS; CROSS-CULTURAL COMPARISON; HUMANS; MENOPAUSE; REPRODUCTION;

EID: 34447300696     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318093df43     Document Type: Conference Paper

References (147)

1. Edwards RG. Pregnancies are acceptable in post-menopausal women. Hum Reprod 1993;8:1542-1544.
2. Paulson RJ, Sauer MV. Regulation of oocyte donation to women over the age of 50: a question of reproductive choice. J Assist Reprod Genet 1994;11:177-182.
3. World Health Organization. Research on the Menopause in the 1990s. WHO Technical Report Series, No. 866. Geneva, Switzerland: World Health Organization, 1996.
4. Ginsberg J. What determines the age at the menopause? BMJ 1991;302:1288-1289.
5. Nichols SM, Bavister BD, Brenner CA, Didier PJ, Harrison RM, Kubisch HM. Ovarian senescence in the rhesus monkey (Macaca mulatta). Hum Reprod 2005;20:79-83.
6. Gilardi KV, Shideler SE, Valverde CR, Roberts JA, Lasley BL. Characterization of the onset of menopause in the rhesus macaque. Biol Reprod 1997;57:335-340.
7. Walker ML. Menopause in female rhesus monkeys. Am J Primatol 1995;35:59-71.
8. Hawkes K. Grandmothers and the evolution of human longevity. Am J Hum Biol 2003;15:380-400.
9. Lahdenpera M, Lummaa V, Helle S, Tremblay M, Russell AF. Fitness benefits of prolonged post-reproductive lifespan in women. Nature 2004;428:178-181.
10. Smith KR, Mineau GP, Bean LL. Fertility and post-reproductive longevity. Soc Biol 2002;49:185-205.
11. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004;428:145-150.
12. Johnson J, Bagley J, Skaznik-Wikiel M, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 2005;122:303-315.
13. Bukovsky A, Caudle MR, Svetlikova M, Wimalasena J, Ayala ME, Dominguez R. Oogenesis in adult mammals, including humans: a review. Endocrine 2005;26:301-316.
14. Byskov AG, Faddy MJ, Lemmen JG, Andersen CY. Eggs forever? Differentiation 2005;73:438-446.
15. Eggan K, Jurga S, Gosden R, Min IM, Wagers AJ. Ovulated oocytes in adult mice derive from non-circulating germ cells. Nature 2006;441:1109-1114.
16. Kerr JB, Duckett R, Myers M, Britt KL, Mladenovska T, Findlay JK. Quantification of healthy follicles in the neonatal and adult mouse ovary: evidence for maintenance of primordial follicle supply. Reproduction 2006;132:95-109.
17. Liu Y, Wu C, Lyu Q, et al. Germline stem cells and neo-oogenesis in the adult human ovary [E-pub]. Dev Biol 2007 Mar 12.
18. Telfer EE, Gosden RG, Byskov AG, et al. On regenerating the ovary and generating controversy. Cell 2005;122:821-822.
19. Zeleznik AJ, Benyo DF. Control of follicular development, corpus luteum function, and the recognition of pregnancy in higher primates. In: Knobil E, Neill JD, eds. The Physiology of Reproduction, 2nd. New York, NY: Raven Press, 1994:751-782.
20. Finch CE, Kirkwood TBL. Chance, Development, and Aging. New York, NY: Oxford University Press, 2000.
21. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231-1237.
22. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992;7:1342-1346.
23. Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 1996;11:1484-1486.
24. Gougeon A, Ecochard R, Thalabard JC. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod 1994;50:653-663.
25. Leidy L, Godfrey L, Sutherland M. Is follicular atresia biphasic? Fertil Steril 1998;70:851-859.
26. Holman DJ, O'Connor KA, Brindle E, Wood JW, Mansfield PK, Weinstein M. Ovarian follicular development in postmenopausal women [Abstract]. Am J Hum Biol 2002;14:115.
27. Ellison PT. On Fertile Ground: A Natural History of Human Reproduction. Boston, MA: Harvard University Press, 2001.
28. Leidy Sievert L. Menopause: A Biocultural Perspective. New Brunswick, NJ: Rutgers University Press, 2006.
29. Wood JW. Dynamics of Human Reproduction: Biology, Biometry, Demography. New York, NY: Aldine de Gruyter, 1994.
30. Hardy R, Kuh D. Does early growth influence timing of the menopause? Evidence from a British birth cohort. Hum Reprod 2002;17:2474-2479.
31. Hardy R, Kuh D. Menopause and gynaecological disorders: a life course perspective. In: Kuh D, Hardy R, eds. A Lifecourse Approach to Wome's Health. Oxford, UK: Oxford University Press, 2002:64-85.
32. Goodman M, Estioko-Griffin A, Griffin P, Grove J. Menarche, pregnancy, birth spacing and menopause among the Agta women foragers of Cagayan Province, Luzon, the Philippines. Ann Hum Biol 1985;12:169-177.
33. Sarin AR, Singla P, Sudershan KG. A 5-year clinicopathological study of 2000 postmenopausal women from northern India. Asia-Oceania J Obstet Gynaecol 1985;11:539-544.
34. Thomas F, Francois R, Benefice E, de Meeus T, Guegan JF. International variability of ages at menarche and menopause. Hum Biol 2001;73:271-290.
35. Wasti S, Robinson SC, Akhtar T, Khan S, Badaruddin N. Characteristics of menopause in three socioeconomic urban groups in Karachi, Pakistan. Maturitas 1993;16:61-69.
36. World Health Organization. Research on the Menopause. WHO Technical Report Series, No. 670. Geneva, Switzerland: World Health Organization, 1981.
37. Wood JW, Johnson PL, Campbell KL. Demographic and endocrinological aspects of low natural fertility in highland New Guinea. J Biosoc Sci 1985;17:57-79.
38. Snowdon DA, Kane RL, Beeson WL, et al. Is early natural menopause a biologic marker of health and aging? Am J Public Health 1989;79:709-714.
39. Ossewaarde ME, Bots ML, Verbeek AL, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005;16:556-562.
40. Cramer DW, Welch WR, Cassells S, Scully RE. Mumps, menarche, menopause, and ovarian cancer. Am J Obstet Gynecol 1983;147:1-6.
41. Elias SG, van Noord PA, Peeters PH, den Tonkelaar I, Grobbee DE. Caloric restriction reduces age at menopause: the effect of the 1944-1945 Dutch famine. Menopause 2003;10:399-405.
42. Hardy R, Kuh D. Social and environmental conditions across the life course and age at menopause in a British birth cohort study. BJOG 2005;112:346-354.
43. Johnston SL. Associations with age at natural menopause in Blackfeet women. Am J Hum Biol 2001;13:512-520.
44. Peccei JS. First estimates of heritability in the age of menopause. Curr Anthropol 1999;40:553-558.
45. Larke A, Crews DE. Parental investment, late reproduction, and increased reserve capacity are associated with longevity in humans. J Physiol Anthropol 2006;25:119-131.
46. Lycett JE, Dunbar RI, Voland E. Longevity and the costs of reproduction in a historical human population. Proc Biol Sci 2000;267:31-35.
47. Westendorp RG, Kirkwood TB. Human longevity at the cost of reproductive success. Nature 1998;396:743-746.
48. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-356.
49. Boulet MJ, Oddens BJ, Lehert P, Vemer HM, Visser A. Climacteric and menopause in seven South-east Asian countries. Maturitas 1994;19:157-176.
50. Freeman EW, Sammel MD, Gracia CR, et al. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril 2005;83:383-392.
51. Goldin BR, Adlercreutz H, Gorbach SL, et al. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 1986;44:945-953.
52. Ellison PT, Panter-Brick C, Lipson SF, O'Rourke MT. The ecological context of human ovarian function. Hum Reprod 1993;8:2248-2258.
53. Ellison PT, Lipson SF, O'Rourke MT, et al. Population variation in ovarian function. Lancet 1993;342:433-434.
54. Lipson SF, Ellison PT. Normative study of age variation in salivary progesterone profiles. J Biosoc Sci 1992;24:233-244.
55. Núñez-de la Mora A, Chatterton RT, Choudhury O, Napolitano O, Bentley GR. Childhood conditions influence adult progesterone levels. PLOS Med 2007 May 15;4(5):e167 [Epub ahead of print].
56. Núñez-de la Mora A, Bentley GR, Chatterton RT, Choudhury O, Napolitano O. The impact of developmental conditions on adult salivary estradiol levels: why this differs from progesterone. Am J Hum Biol 2007. In press.
57. Randolph JF, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ. Changes in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555-1561.
58. Santoro N, Lasley B, McConnell D, et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: the Study of Women's Health Across the Nation (SWAN) daily hormone study. J Clin Endocrinol Metab 2004;89:2622-2631.
59. Johnson MH, Everitt BJ. Essential Reproduction, 5th ed. Oxford, UK: Blackwell Science, 2000.
60. Cohen HL, Tice HM, Mandel FS. Ovarian volumes measured by US: bigger than we think. Radiology 1990;177:189-192.
61. Merz E, Miric-Tesanic D, Bahlmann F, Weber G, Wellek S. Sonographic size of uterus and ovaries in pre- and postmenopausal women. Ultrasound Obstet Gynecol 1996;7:38-42.
62. Pavlik EJ, DePriest PD, Gallion HH, et al. Ovarian volume related to age. Gynecol Oncol 2000;77:410-412.
63. Bastos CA, Oppermann K, Fuchs SC, Donato GB, Spritzer PM. Determinants of ovarian volume in pre-, menopausal transition, and post-menopausal women: a population-based study. Maturitas 2006;53:405-412.
64. Ng EH, Yeung WS, Fong DY, Ho PC. Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility. Hum Reprod 2003;18:2169-2174.
65. Christensen JT, Boldsen J, Westergaard JG. Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception. Acta Obstet Gynecol Scand 1997;76:784-789.
66. Jokubkiene L, Sladkevicius P, Rovas L, Valentin L. Assessment of changes in volume and vascularity of the ovaries during the normal menstrual cycle using three-dimensional power Doppler ultrasound. Hum Reprod 2006;21:2661-2668.
67. Elter K, Sismanoglu A, Durmusoglu F. Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: a prospective study. Gynecol Endocrinol 2005;20:137-143.
68. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 1963;158:417-433.
69. Block E. Quantitative morphological investigations of the follicular system in women. II. Variations at different ages. Acta Anat 1952;14:108-123.
70. Block E. A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anat 1953;17:201-206.
71. Forabosco A, Sforza C, De Pol A, Vizzotto L, Marzona L, Ferrario VF. Morphometric study of the human neonatal ovary. Anat Rec 1991;231:201-208.
72. Ibanez L, Potau N, Enriquez G, de Zegher F. Reduced uterine and ovarian size in adolescent girls born small for gestational age. Pediatr Res 2000;47:575-577.
73. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
74. Knight PG, Glister C. Regulation of production and intraovarian roles of inhibin, activin, and follistatin. In: Muttukrishna S, Ledger W, eds. Inhibin, Activin, and Follistatin in Human Reproductive Physiology. London, UK: Imperial College Press, 2001.
75. Hughes EG, King C, Wood EC. A prospective study of prognostic factors in in vitro fertilization and embryo transfer. Fertil Steril 1989;51:838-844.
76. Meldrum DR. Female reproductive aging-ovarian and uterine factors. Fertil Steril 1993;59:1-5.
77. Navot D, Drews MR, Berg PA, et al. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril 1994;61:97-101.
78. Scott RT, Opsahl MS, Leonardi MR, Neall GS, Illions EH, Navot D. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 1995;10:1706-1710.
79. Cahill DJ, Prosser CJ, Wardle PG, Ford WCL, Hull MGR. Relative influence of serum follicle stimulating hormone, age, and other factors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1994;101:999-1002.
80. Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B. Evaluating ovarian reserve: follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod 1996;11:486-489.
81. Pearlstone AC, Fournet N, Gambone JC, Pang SC, Buyalos RP. Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril 1992;58:674-679.
82. Toner JP. The significance of elevated FSH for reproductive function. Baillieres Clin Obstet Gynecol 1993;7:283-295.
83. Buckman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 2001;7:581-590.
84. Corson SL, Gutmann J, Batzer FR, Wallace H, Klein N, Soules MR. Inhibin-B as a test of ovarian reserve for infertile women. Hum Reprod 1999;14:2818-2821.
85. Dzik A, Lambert-Messerlian G, Izzo VM, Soares JB, Pinotti JA, Seifer DB. Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. Fertil Steril 2000;74:1114-1117.
86. Kwee J, Elting MW, Schats R, Bezemer PD, Lambalk CB, Schoemaker J. Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod 2003;18:1422-1427.
87. Ranieri DM, Phophong P, Khadum I, Meo F, Davis C, Serhal P. Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF. Hum Reprod 2001;16:673-675.
88. Creus M, Penarrubia J, Fabregues F, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000;15:2341-2346.
89. Danforth DR, Arbogast LK, Mroueh J, et al. Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 1998;70:119-123.
90. Millot F, Antoine JM, Merviel P, Mathieu E, Carpeau J, Uzan S. Comparison of predictive values of inhibins A and B, and plasma estradiol in IVF patients treated with GnRH agonists and recombinant FSH [in French]. Gynecol Obstet Fertil 2002;30:36-41.
91. Seifer DB, Scott RT, Bergh PA, et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 1999;72:63-65.
92. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105-111.
93. Van Rooij IAJ, Broekmans FJM, te Velde ER, et al. Serum anti mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-3071.
94. Banci L, Broekmans F, Eijkemans M, de Jong F, Habbema D, Velde E. Predictors in poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-336.
95. Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 2005;112:1384-1390.
96. Canning J, Takai Y, Tilly JL. Evidence for genetic modifiers of ovarian follicular endowment and development from studies of five inbred mouse strains. Endocrinology 2003;144:9-12.
97. Jasienska G, Kapiszewska M, Ellison PT, et al. CYP17 genotypes differ in salivary 17-A estradiol levels: a study based on hormonal profiles from entire menstrual cycles. Cancer Epidemiol Biomarkers Prev 2006;15:2131-2135.
98. Small CM, Marcus M, Sherman SL, Sullivan AK, Manatunga AK, Feigelson HS. CYP17 genotype predicts serum hormone levels among pre-menopausal women. Hum Reprod 2005;20:2162-2167.
99. Georgiou I, Konstantelli M, Syrrou M, Messinis IE, Lolis DE. Oestrogen receptor gene polymorphisms and ovarian stimulation for in-vitro fertilization. Hum Reprod 1997;12:1430-1433.
100. Sundarrajan C, Liao W, Roy AC, Ng SC. Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF. Mol Hum Reprod 1999;5:797-802.
101. Purcell K, Schembri M, Frazier LM, et al. Asian ethnicity is associated with reduced pregnancy outcomes after assisted reproductive technology. Fertil Steril 2007;87:297-302.
102. Ellison PT. Advances in human reproductive ecology. Annu Rev Anthropol 1994;23:255-275.
103. Ellison PT. Developmental influences on adult ovarian hormonal function. Am J Hum Biol 1996;8:725-734.
104. de Bruin JP, Dorland M, Bruinse HW, Spliet W, Nikkels PG, Te Velde ER. Fetal growth retardation as a cause of impaired ovarian development. Early Hum Dev 1998;51:39-46.
105. Cresswell JL, Egger P, Fall CH, Osmond C, Fraser RB, Barker DJ. Is the age of menopause determined in-utero? Early Hum Dev 1997;49:143-148.
106. Jasienska G, Ziomkiewicz A, Lipson SF, Thune I, Ellison PT. High ponderal index at birth predicts high estradiol levels in adult women. Am J Hum Biol 2006;18:133-140.
107. Polk JD, Merlino JI, Kovach BL, Mancuso C, Fallon WF Jr. Fetal evaluation for transport by ultrasound performed by air medical teams: a case series. Air Med J 2004;23:32-34.
108. Stamilio DM, McReynolds T, Endrizzi J, Lyons RC. Diagnosis and treatment of a ruptured ectopic pregnancy in a combat support hospital during Operation Iraqi Freedom: case report and critique of a field-ready sonographic device. Mil Med 2004;169:681-683.
109. Bennett CC, Richards DS. Patient acceptance of endovaginal ultrasound. Ultrasound Obstet Gynecol 2000;15:52-55.
110. Jarvela IY, Sladkevicius P, Tekay AH, Campbell S, Nargund G. Intraobserver and interobserver variability of ovarian volume, gray-scale and color flow indices obtained using transvaginal three-dimensional power Doppler ultrasonography. Ultrasound Obstet Gynecol 2003;21:277-282.
111. Merce LT, Gomez B, Engels V, Bau S, Bajo JM. Intraobserver and interobserver reproducibility of ovarian volume, antral follicle count, and vascularity indices obtained with transvaginal 3-dimensional ultrasonography, power Doppler angiography, and the virtual organ computer-aided analysis imaging program. J Ultrasound Med 2005;24:1279-1287.
112. Rovas L, Sladkevicius P, Strobel E, Valentin L. Intraobserver and interobserver reproducibility of three-dimensional gray-scale and power Doppler ultrasound examinations of the cervix in pregnant women. Ultrasound Obstet Gynecol 2005;26:132-137.
113. Valentin L, Bergelin I. Intra- and interobserver reproducibility of ultrasound measurements of cervical length and width in the second and third trimesters of pregnancy. Ultrasound Obstet Gynecol 2002;20:256-262.
114. Tsianakas V, Liamputtong P. What women from an Islamic background in Australia say about care in pregnancy and prenatal testing. Midwifery 2002;18:25-34.
115. Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988;3:851-855.
116. Muttukrishna S, Child T, Lockwood G, Groome NP, Barlow D, Ledger W. Serum concentrations of dimeric inhibins, activin A, pituitary gonadotrophins and ovarian steroids during the menstrual cycle in older women. Hum Reprod 2000;15:549-556.
117. Gracia CR, Sammel MD, Freeman EW, et al. Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause 2005;12:128-135.
118. Baird DT, Smith KB. Inhibin and related peptides in the regulation of reproduction. Oxf Rev Reprod Biol 1993;15:191-232.
119. Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol 1981;14:245-255.
120. Rannevik G, Carlstrom K, Jeppsson S, Bjerre B, Svanberg L. A prospective long-term study in women from premenopause to postmenopause: changing profiles of gonadotrophins, oestrogens, and androgens. Maturitas 1986;8:297-307.
121. Reame NE, Kelche RP, Beitins IZ, Yu MY, Zawacki CM, Padmanabhan V. Age effects of FSH and pulsatile LH secretion across the menstrual cycle of premenopausal women. J Clin Endocrinol Metab 1996;81:1512-1518.
122. Santoro N. Hormonal changes in the perimenopause. Clin Consultat Obstet Gynecol 1996;8:2-8.
123. Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-1405.
124. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and anti-mullerian hormone: markers of ovarian response in IVF/ICSI patients? BJOG 2004;111:1248-1253.
125. Lee MM, Donahoe PK, Hasegawa T, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-576.
126. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE. Expression of anti-mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999;84:3836-3844.
127. Sweeney T, Saunders PT, Millar MR, Brooks AN. Ontogeny of anti-mullerian hormone, 3 β-hydroxysteroid dehydrogenase and androgen receptor expression during ovine total gonadal development. J Endocrinol 1997;153:27-32.
128. Van Rooij IAJ, Broekmans FJM, te Velde ER, et al. Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-3071.
129. Voutilainen R, Miller WL. Human mullerian inhibitory factor messenger ribonucleic acid is hormonally regulated in the fetal testis and in adult granulosa cells. Mol Endocrinol 1987;1:604-608.
130. Cook CL, Siow Y, Taylor S, Fallat ME. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000;73:859-861.
131. Fallat ME, Siow Y, Marra M, Cook C, Carrillo A. Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil Steril 1997;67:962-965.
132. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004;89:318-323.
133. De Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-362.
134. Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001;142:4891-4899.
135. Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076-1084.
136. Kezele P, Nilsson E, Skinner MK. Cell-cell interactions in primordial follicle assembly and development. Front Biosci 2002;7:d1990-d1996.
137. Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update 2005;11:461-471.
138. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006;91:4057-4063.
139. Shirtcliff EA, Granger DA, Schwartz EB, Curran MJ, Booth A, Overman WH. Assessing estradiol in biobehavioral studies using saliva and blood spots: simple radioimmunoassay protocols, reliability, and comparative validity. Horm Behav 2000;38:137-147.
140. Shirtcliff EA, Reavis R, Overman WH, Granger DA. Measurement of gonadal hormones in dried blood spots versus serum: verification of menstrual cycle phase. Horm Behav 2001;39:258-266.
141. Worthman CM, Stallings JF. Measurement of gonadotropins in dried blood spots. Clin Chem 1994;40:448-453.
142. Worthman CM, Stallings JF. Hormone measures in finger-prick blood spot samples: new field methods for reproductive endocrinology. Am J Phys Anthropol 1997;104:1-21.
143. Brindle E, Miller RC, Shofer JB, Klein NA, Soules MR, O'Connor KA. Urinary β-luteinizing hormone and β-follicle stimulating hormone immunoenzymometric assays for population research. Clin Biochem 2006;39:1071-1079.
144. Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
145. Sowers MR, Jannausch ML, McConnell DS, Kardia SR, Randolph JF Jr. Menstrual cycle markers of ovarian aging and sex steroid hormone genotypes. Am J Med 2006;119(Suppl 1):S31-S43.
146. Knott CD. Radioimmunoassay of estrone conjugates from urine dried on filter paper. Am J Primatol 2005;67:121-135.
147. Shimizu K. Studies on reproductive endocrinology in non-human primates: application of non-invasive methods. J Reprod Dev 2005;51:1-13.